Chapter 22 Antihypertensive drugs Flashcards
Hypertension, defined as a persistent systolic blood pressure (SBP) of greater than?
150 mm Hg and/or a diastolic blood pressure (DBP) greater than 90 mm Hg for patients 60 years or older and SBP greater than 140 and DBP greater than 90
for patients younger than 60 and those who have chronic kidney disease or diabetes.
Hypertension is a major risk factor?
coronary artery disease, cardiovascular disease, and death resulting from cardiovascular causes. It is the most important risk factor for stroke and heart failure, and it is also a major risk factor for renal failure and peripheral vascular disease.
Blood pressure is determined by the product of cardiac
output and systemic vascular resistance (SVR). All antihypertensives in some way affect?
cardiac output
Cardiac output is the amount of blood that is ejected from the left ventricle. SVR is the resistance to blood flow that is determined by the diameter of the blood vessel and the vasculature musculature. If the cause of hypertension is unknown, it may be called?
essential, idiopathic, or primary hypertension, comprising 90% of cases.
Secondary hypertension is most commonly the result of
another disease such as?
pheochromocytoma, preeclampsia of pregnancy, renal artery disease, sleep apnea, thyroid disease, or parathyroid disease or the use of certain medications.
If the cause of secondary hypertension can be eliminated,
blood pressure usually returns to normal.
If untreated, hypertension can cause damage to?
end organs such as the heart, brain, kidneys, and eyes.
According to the JNC-8, therapy should be started if blood pressure is at or greater than?
150/90 for patients over 60 years and 140/90 for patients younger than 60 and those who have chronic kidney disease or diabetes.
Seven main categories of pharmacologic drugs used to treat hypertension include:
(1) diuretics
(2) adrenergic drugs
(3) vasodilators
(4) angiotensin-converting enzyme (ACE)
inhibitors
(5) angiotensin receptor blockers (ARBs)
(6) calcium channel blockers (CCBs)
(7) direct renin inhibitors
-All of these antihypertensive drugs (with the exception
of diuretics) have some vasodilatory action. Those drugs in the vasodilator category are also called direct vasodilators
-Drugs in any of these classes may be used either alone or in combination
Adrenergic Drugs
• Five specific drug subcategories are included in the adrenergic antihypertensive drugs, which have?
central action (in the brain) or peripheral action (at the heart and blood vessels).
The centrally acting adrenergic drugs work by?
stimulating the alpha2-adrenergic receptors in the brain. This results in a lack of norepinephrine production, which reduces blood pressure
Stimulation of the alpha2-adrenergic receptors also affects the?
kidneys, reducing the activity of renin. Renin is the hormone and enzyme that converts the protein precursor angiotensinogen to the protein angiotensin I, the precursor of angiotensin II (AII), a potent vasoconstrictor that raises blood pressure.
In the periphery, the alpha1 blockers doxazosin, prazosin,
and terazosin also modify the function of the sympathetic
nervous system. They do so by?
blocking the alpha1- adrenergic receptors. When these receptors are blocked, blood pressure is decreased.
The beta blockers also act in the periphery and include propranolol, metoprolol, and atenolol as well as several other drugs. Their antihypertensive effects are related to their?
reduction of the heart rate through beta1-receptor blockade. Beta blockers also cause a reduction in the secretion of the hormone renin, which in turn reduces both AII-mediated vasoconstriction and aldosterone-mediated volume expansion. Long-term use of beta blockers also reduces peripheral vascular resistance.
Nebivolol (Bystolic) is the newest beta blocker, released in 2008. It is a?
beta1-selective beta blocker approved for use in
hypertension. It is also used for the treatment of heart failure.
The most common adverse effects of adrenergic drugs are?
bradycardia with reflex tachycardia, postural and postexercise hypotension, dry mouth, drowsiness, dizziness, depression, edema, constipation, and sexual dysfunction. Other effects include headaches, sleep disturbances, nausea, rash, and palpitations.
There is a high incidence of orthostatic hypotension in
patients taking?
alpha blockers. When the patient changes positions, a situation known as first-dose syncope, in which the hypotensive effect is severe enough to cause the patient
to lose consciousness with even the first dose of medication, can occur. Educate the patient to change positions slowly.
The abrupt discontinuation of the centrally acting alpha2-
receptor agonists can result in?
rebound hypertension, characterized by a sudden and very high elevation of blood pressure.
Nonselective blocking drugs are also commonly associated with?
bronchoconstriction as well as metabolic inhibition of
glycogenolysis in the liver, which can lead to hypoglycemia.
Any change in the dosing regimen for cardiovascular medications should be?
undertaken gradually and with appropriate patient monitoring and follow-up.
ACE inhibitors work by?
blocking a critical enzyme system responsible for the production of AII (a potent vasoconstrictor). They prevent vasoconstriction caused by AII, prevent aldosterone secretion and therefore sodium and water resorption, and prevent the breakdown of bradykinin (a potent vasodilator) by AII.
Currently, there are 10 ACE inhibitors available for clinical
use, including:
(1) captopril (Capoten)
(2) enalapril (Vasotec)
(3) lisinopril (Prinivil)
• These drugs are very safe and efficacious and are often used as first-line drugs in the treatment of both heart failure and hypertension.
The therapeutic effects of the ACE inhibitors are related to their?
potent cardiovascular effects. They may be used alone
or in combination with other drugs, such as diuretics, in the treatment of hypertension or heart failure.
Because of their ability to decrease SVR and preload, ACE inhibitors can stop the progression of?
left ventricular hypertrophy (sometimes seen after a myocardial infarction [MI]), a pathologic process known as ventricular remodeling. The ability of ACE inhibitors to prevent this is termed a cardioprotective effect.
ACE inhibitors have been shown to have a protective effect on the?
kidneys because they reduce glomerular filtration
pressure. This is one of the reasons that they are among the cardiovascular drugs of choice for diabetic patients.
Central nervous system effects of the ACE inhibitors include?
fatigue, dizziness, mood changes, headaches, and a characteristic dry, nonproductive cough reversible with discontinuation of the therapy
The most pronounced symptom of an overdose for ACE inhibitors is?
hypotension.
Treatment is symptomatic and supportive and includes
the administration of intravenous (IV) fluids to expand
volume.
All ACE inhibitors have detrimental effects on?
the unborn fetus and neonate.
ARBs are similar to the ACE inhibitors. The class includes?
losartan (Cozaar)
valsartan (Diovan)
In contrast to ACE inhibitors, the ARBs affect primarily?
vascular smooth muscle and the adrenal gland. By selectively blocking the binding of AII to the type 1 AII receptors in these tissues, ARBs block vasoconstriction and the secretion of aldosterone. The end result is a decrease in blood pressure. Clinically, ACE inhibitors and ARBs appear to be equally effective for the treatment of hypertension, but ARBs do not cause cough. ARBs are better tolerated and are associated with lower mortality after MI than ACE inhibitors. It is not yet clear whether ARBs are as effective as ACE inhibitors in treating heart failure (cardioprotective effects) or in protecting the kidneys, as in diabetes.
Both types of drugs, ARBs & ACE inhibitors, are contraindicated for use in?
the second or third trimester of pregnancy.
The therapeutic effects of ARBs are related to their?
potent vasodilating properties. The beneficial hemodynamic effect of ARBs is their ability to decrease SVR (measure of afterload)
- they are excellent antihypertensives and adjunctive drugs for Tx of heart failure
- may be used alone or in combination w/other drugs such as diuretics in the Tx of HTN or heart failure
The most common adverse effects of ARBs are?
upper respiratory tract infections and headache. Occasionally, dizziness, inability to sleep, diarrhea, dyspnea, heartburn, nasal congestion, back pain, and fatigue can occur. Hyperkalemia is less likely than with the ACE inhibitors